CHARTWELL INVESTMENT PARTNERS, LLC - VIKING THERAPEUTICS INC ownership

VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 187 filers reported holding VIKING THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.

Quarter-by-quarter ownership
CHARTWELL INVESTMENT PARTNERS, LLC ownership history of VIKING THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$1,035
-60.0%
19,507
-38.2%
0.04%
-60.0%
Q1 2024$2,588
+155.5%
31,563
-42.1%
0.09%
+150.0%
Q4 2023$1,013
+47.9%
54,469
-11.9%
0.04%
+33.3%
Q3 2023$685
-99.9%
61,8190.0%0.03%
-25.0%
Q2 2023$1,002,086
+117240.3%
61,819
+20.4%
0.04%
+12.5%
Q1 2023$854
+3.4%
51,328
-41.6%
0.03%
-3.0%
Q4 2022$82687,8420.03%
Other shareholders
VIKING THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
APIS CAPITAL ADVISORS, LLC 148,000$1,638,3602.12%
Sio Capital Management, LLC 595,002$6,586,6722.04%
5AM Venture Management, LLC 585,000$6,475,9501.86%
Artia Global Partners LP 383,580$4,246,2311.76%
Integral Health Asset Management, LLC 800,000$8,856,0001.23%
Boxer Capital, LLC 2,000,000$22,140,0001.18%
DAFNA Capital Management LLC 319,655$3,538,5811.10%
Affinity Asset Advisors, LLC 332,600$3,681,8821.04%
MPM BioImpact LLC 325,000$3,597,7500.96%
Affinity Asset Advisors, LLC 300,000$3,321,0000.93%
View complete list of VIKING THERAPEUTICS INC shareholders